CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $32 | -85.0% | 7,604 | -78.6% | 0.00% | -88.9% |
Q4 2022 | $213 | -99.6% | 35,456 | +282.2% | 0.01% | +800.0% |
Q3 2022 | $54,000 | -64.9% | 9,276 | -64.2% | 0.00% | -66.7% |
Q2 2022 | $154,000 | +156.7% | 25,919 | +102.6% | 0.00% | +200.0% |
Q1 2022 | $60,000 | +1.7% | 12,792 | -45.8% | 0.00% | 0.0% |
Q4 2021 | $59,000 | +490.0% | 23,586 | +630.2% | 0.00% | – |
Q3 2021 | $10,000 | -87.0% | 3,230 | -86.5% | 0.00% | -100.0% |
Q4 2020 | $77,000 | +220.8% | 23,865 | +110.6% | 0.00% | – |
Q3 2020 | $24,000 | – | 11,330 | +2656.7% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 411 | -83.9% | 0.00% | – |
Q4 2019 | $4,000 | -73.3% | 2,554 | -85.4% | 0.00% | -100.0% |
Q2 2019 | $15,000 | +400.0% | 17,495 | +563.4% | 0.00% | – |
Q1 2019 | $3,000 | -76.9% | 2,637 | -84.9% | 0.00% | -100.0% |
Q4 2018 | $13,000 | +44.4% | 17,434 | +318.3% | 0.00% | 0.0% |
Q3 2018 | $9,000 | -86.6% | 4,168 | -69.2% | 0.00% | -75.0% |
Q2 2018 | $67,000 | +204.5% | 13,530 | +137.2% | 0.00% | +100.0% |
Q1 2018 | $22,000 | +69.2% | 5,705 | +35.9% | 0.00% | +100.0% |
Q3 2017 | $13,000 | – | 4,199 | +2899.3% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 140 | -89.9% | 0.00% | -100.0% |
Q1 2017 | $6,000 | – | 1,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|